The headline numbers for Myriad (MYGN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...
Myriad Genetics (MYGN) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago. These figures are ...
Genetic testing company Myriad Genetics (NASDAQ:MYGN) fell short of the market’s revenue expectations in Q4 CY2024, but sales ...
Myriad Genetics (MYGN) announced that its board has appointed Sam Raha, the company’s current COO, as president and CEO and as a member of the ...
Reports Q4 revenue $210.6M, consensus $210.35M. “There is a lot for Myriad Genetics (MYGN) to be proud of in 2024. We generated 11% revenue ...
Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be reporting results tomorrow after market hours. Here’s what you ...
StockNews.com lowered shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a buy rating to a hold rating in a research ...
Myriad Genetics (NASDAQ:MYGN – Get Free Report) will likely be announcing its earnings results before the market opens on Tuesday, February 25th. Analysts expect the company to announce earnings of $0 ...